Genomic analysis of cancer will lead to better understanding of cancer biology and help to generate tumour and circulatory molecular markers, that aid early diagnosis and improve the management of the cancer.
The main objective of the project is the meta-analysis of published metastatic prostate cancer data sets to generate changes seen to further define pathways for analysis. The project aims to develop molecular markers that characterize Advanced Prostate Cancer and also identify potential marker that can identify the patients early that can improve the understanding of the basis of cancer and pathways.